Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Study Reports Real-World Results on Use of New Percutaneous Device to Treat Brain Aneurysms
01/07/2022
A recent international study led by researchers at Massachusetts General Hospital (MGH) and other institutions offers real-world results on the use of a novel device for treating brain aneurysms.
A recent international study led by researchers at Massachusetts General Hospital (MGH) and other institutions offers real-world results on the use of a novel device for treating brain aneurysms.
A recent international study led...
01/07/2022
Cath Lab Digest
News
Thrombolytic Science Granted a Second US Patent on Its Clot Dissolving Therapy, a Novel, Nature-inspired Treatment for Ischemic Strokes
01/06/2022
CAMBRIDGE, MA, January 05, 2022 -- Thrombolytic Science, LLC (TSI) has been granted a second patent by the USPTO. The patent was granted for a novel treatment applicable to ischemic stroke, one of the leading causes of morbidity and...
CAMBRIDGE, MA, January 05, 2022 -- Thrombolytic Science, LLC (TSI) has been granted a second patent by the USPTO. The patent was granted for a novel treatment applicable to ischemic stroke, one of the leading causes of morbidity and...
CAMBRIDGE, MA, January 05, 2022...
01/06/2022
Vascular Disease Management

Advertisement

News
SyneuRx Announces Oral COVID-19 Antiviral Drug Candidate Pentarlandir Is Showing Effectiveness Against Both the Omicron and Delta COVID-19 Variants
01/06/2022
Acting as Both a Dual Protease and TMPRSS2 Inhibitor, Pentarlandir is About to Enter FDA Phase III Trial
Acting as Both a Dual Protease and TMPRSS2 Inhibitor, Pentarlandir is About to Enter FDA Phase III Trial
Acting as Both a Dual Protease...
01/06/2022
Cath Lab Digest
News
Upstream Peripheral’s GoBack CTO Catheter Aces its Exam
01/04/2022
100-patient study confirms efficiency of Upstream Peripheral’s GoBack Catheter to cross toughest peripheral vascular lesions
100-patient study confirms efficiency of Upstream Peripheral’s GoBack Catheter to cross toughest peripheral vascular lesions
100-patient study confirms...
01/04/2022
Cath Lab Digest
News
100-Patient Study Confirms Efficiency of Upstream Peripheral’s GoBack Catheter to Cross Toughest Peripheral Vascular Lesions
01/04/2022
Upstream Peripheral Technologies announced that its CTO-busting GoBack® Catheter for crossing and reentry was proven very effective for patients undergoing complex revascularizations in lower limb arteries. The findings are based on a...
Upstream Peripheral Technologies announced that its CTO-busting GoBack® Catheter for crossing and reentry was proven very effective for patients undergoing complex revascularizations in lower limb arteries. The findings are based on a...
Upstream Peripheral Technologies...
01/04/2022
Cath Lab Digest

Advertisement

News
Annals of Internal Med: Researchers Reveal Scale of Prevalence of Condition That Can Cause Type 2 Diabetes and High Blood Pressure
01/04/2022
Notably, 70% of patients with mild autonomous cortisol secretion (MACS) were women and most of them were of postmenopausal age (aged over 50).
Notably, 70% of patients with mild autonomous cortisol secretion (MACS) were women and most of them were of postmenopausal age (aged over 50).
Notably, 70% of patients with...
01/04/2022
Cath Lab Digest
News
First Time Genome Editing Made Possible on Cells Lining Blood Vessel Walls
01/04/2022
January 4, 2022 — The lab of Youyang Zhao, PhD, from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago developed a unique nanoparticle to deliver genome editing technology, including...
January 4, 2022 — The lab of Youyang Zhao, PhD, from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago developed a unique nanoparticle to deliver genome editing technology, including...
January 4, 2022 — The lab of...
01/04/2022
Cath Lab Digest
News
JVS: Early Evaluation of Transcarotid Artery Revascularization (TCAR) Versus Carotid Endarterectomy (CEA) Cost-Effectiveness
01/03/2022
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted...
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted...
A cost-effectiveness model based...
01/03/2022
Cath Lab Digest

Advertisement

News
FDA Approves Novartis Leqvio (inclisiran), First-in-Class siRNA to Lower Cholesterol and Keep It Low With Two Doses a Year
12/22/2021
Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran), the first and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) with two doses a year, after an...
Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran), the first and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) with two doses a year, after an...
Novartis today announced the US...
12/22/2021
Cath Lab Digest
News
Philips Receives FDA De Novo Clearance for CavaClear With Breakthrough Device Designation for Laser-Assisted IVC Filter Removal
12/21/2021
Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters   CavaClear is a first-in-class FDA-cleared solution for advanced IVC filter removal   It is...
Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters   CavaClear is a first-in-class FDA-cleared solution for advanced IVC filter removal   It is...
Philips IVC Filter Removal...
12/21/2021
Cath Lab Digest

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use